| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |